Former unicorn genetics startup Human Longevity loses its horn
The company's valuation has declined 80 percent, from a $1.6 billion peak to $310 million, according to The Wall Street Journal.
The company's valuation has declined 80 percent, from a $1.6 billion peak to $310 million, according to The Wall Street Journal.
Genomic sequencing legend Craig Venter now stands accused of stealing trade secrets and attempting to poach employees by the very company he founded.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
J. Craig Venter will step down as CEO of his ambitious genomics-driven biotech Human Longevity, effective January 9.